Inhibition of Japanese encephalitis virus replication by peptide nucleic acids targeting cis-acting elements on the plus- and minus-strands of viral RNA

Antiviral Research

Volumn 82, Issue 3, 2009, Pages 122-133

  Yoo, Ji Seung ^a   Kim, Chan Mi ^a   Kim, Jung Hee ^a   Kim, Jee Yon ^a   Oh, Jong Won ^a  

^a Yonsei University   (South Korea)

Author keywords

Antisense; cis Acting element; JEV; Peptide nucleic acids (PNAs); RdRp

Indexed keywords

CIS ACTING ELEMENT; PEPTIDE NUCLEIC ACID; RNA DIRECTED RNA POLYMERASE; TRANSACTIVATOR PROTEIN; VIRUS RNA;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CELL STRAIN BHK; CONTROLLED STUDY; DRUG EFFICACY; DRUG TARGETING; ENZYME BINDING; JAPANESE ENCEPHALITIS VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA STRUCTURE; RNA SYNTHESIS; VIRUS GENOME; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; BASE SEQUENCE; CELL LINE; CRICETINAE; ENCEPHALITIS VIRUS, JAPANESE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; PEPTIDE NUCLEIC ACIDS; PLAQUE ASSAY; PROTEIN BINDING; RNA, VIRAL; SEQUENCE ALIGNMENT; VIRAL PROTEINS; VIRUS REPLICATION;

JAPANESE ENCEPHALITIS VIRUS;

EID: 64749087893     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2009.02.187     Document Type: Article

References (54)

1. Aizaki H., Lee K.J., Sung V.M., Ishiko H., and Lai M.M. Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts. Virology 324 (2004) 450-461
2. Blackwell J.L., and Brinton M.A. BHK cell proteins that bind to the 3′ stem-loop structure of the West Nile virus genome RNA. J. Virol. 69 (1995) 5650-5658
3. Blackwell J.L., and Brinton M.A. Translation elongation factor-1 alpha interacts with the 3′ stem-loop region of West Nile virus genomic RNA. J. Virol. 71 (1997) 6433-6444
4. Brinton M.A., and Dispoto J.H. Sequence and secondary structure analysis of the 5′-terminal region of flavivirus genome RNA. Virology 162 (1988) 290-299
5. Cahour A., Pletnev A., Vazielle-Falcoz M., Rosen L., and Lai C.J. Growth-restricted dengue virus mutants containing deletions in the 5′ noncoding region of the RNA genome. Virology 207 (1995) 68-76
6. Chambers T.J., Hahn C.S., Galler R., and Rice C.M. Flavivirus genome organization, expression, and replication. Annu. Rev. Microbiol. 44 (1990) 649-688
7. Davis W.G., Blackwell J.L., Shi P.Y., and Brinton M.A. Interaction between the cellular protein eEF1A and the 3′-terminal stem-loop of West Nile virus genomic RNA facilitates viral minus-strand RNA synthesis. J. Virol. 81 (2007) 10172-10187
8. Deas T.S., Bennett C.J., Jones S.A., Tilgner M., Ren P., Behr M.J., Stein D.A., Iversen P.L., Kramer L.D., Bernard K.A., and Shi P.Y. In vitro resistance selection and in vivo efficacy of morpholino oligomers against West Nile virus. Antimicrob. Agents Chemother. 51 (2007) 2470-2482
9. Deas T.S., Binduga-Gajewska I., Tilgner M., Ren P., Stein D.A., Moulton H.M., Iversen P.L., Kauffman E.B., Kramer L.D., and Shi P.Y. Inhibition of flavivirus infections by antisense oligomers specifically suppressing viral translation and RNA replication. J. Virol. 79 (2005) 4599-4609
10. Decker C.J., and Parker R. Diversity of cytoplasmic functions for the 3′ untranslated region of eukaryotic transcripts. Curr. Opin. Cell Biol. 7 (1995) 386-392
11. Dreher T.W. Functions of the 3′-untranslated regions of positive strand RNA viral genomes. Annu. Rev. Phytopathol. 37 (1999) 151-174
12. Hahn C.S., Hahn Y.S., Rice C.M., Lee E., Dalgarno L., Strauss E.G., and Strauss J.H. Conserved elements in the 3′ untranslated region of flavivirus RNAs and potential cyclization sequences. J. Mol. Biol. 198 (1987) 33-41
13. Holden K.L., Stein D.A., Pierson T.C., Ahmed A.A., Clyde K., Iversen P.L., and Harris E. Inhibition of dengue virus translation and RNA synthesis by a morpholino oligomer targeted to the top of the terminal 3′ stem-loop structure. Virology 344 (2006) 439-452
14. Khromykh A.A., Meka H., Guyatt K.J., and Westaway E.G. Essential role of cyclization sequences in flavivirus RNA replication. J. Virol. 75 (2001) 6719-6728
15. Khromykh A.A., and Westaway E.G. Subgenomic replicons of the flavivirus Kunjin: construction and applications. J. Virol. 71 (1997) 1497-1505
16. Kim S.J., Kim J.H., Kim Y.G., Lim H.S., and Oh J.W. Protein kinase C-related kinase 2 regulates hepatitis C virus RNA polymerase function by phosphorylation. J. Biol. Chem. 279 (2004) 50031-50041
17. Kim Y.G., Yoo J.S., Kim J.H., Kim C.M., and Oh J.W. Biochemical characterization of a recombinant Japanese encephalitis virus RNA-dependent RNA polymerase. BMC Mol. Biol. 8 (2007) 59
18. Kinney R.M., Huang C.Y., Rose B.C., Kroeker A.D., Dreher T.W., Iversen P.L., and Stein D.A. Inhibition of dengue virus serotypes 1 to 4 in Vero cell cultures with morpholino oligomers. J. Virol. 79 (2005) 5116-5128
19. Kumar P., Lee S.K., Shankar P., and Manjunath N. A single siRNA suppresses fatal encephalitis induced by two different flaviviruses. PLoS Med. 3 (2006) e96
20. Leyssen P., Charlier N., Paeshuyse J., De Clercq E., and Neyts J. Prospects for antiviral therapy. Adv. Virus Res. 61 (2003) 511-553
21. Leyssen P., De Clercq E., and Neyts J. Perspectives for the treatment of infections with Flaviviridae. Clin. Microbiol. Rev. 13 (2000) 67-82
22. Lindenbach B.D., and Rice C.M. Molecular biology of flaviviruses. Adv. Virus Res. 59 (2003) 23-61
23. Lundin K.E., Good L., Strömberg R., Gräslund A., and Smith C.I. Biological activity and biotechnological aspects of peptide nucleic acid. Adv. Genet. 56 (2006) 1-51
24. Mackenzie J.S., Gubler D.J., and Petersen L.R. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat. Med. 10 (2004) S98-109
25. Markoff L. 5′- and 3′-noncoding regions in flavivirus RNA. Adv. Virus Res. 59 (2003) 177-228
26. Miller S., Kastner S., Krijnse-Locker J., Bühler S., and Bartenschlager R. The non-structural protein 4A of dengue virus is an integral membrane protein inducing membrane alterations in a 2K-regulated manner. J. Biol. Chem. 282 (2007) 8873-8882
27. Nielsen P.E., Egholm M., Berg R.H., and Buchardt O. Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science 254 (1991) 1497-1500
28. Oh J.W., Sheu G.T., and Lai M.M. Template requirement and initiation site selection by hepatitis C virus polymerase on a minimal viral RNA template. J. Biol. Chem. 275 (2000) 17710-17717
29. Parida M., Dash P.K., Tripathi N.K., Ambuj, Sannarangaiah S., Saxena P., Agarwal S., Sahni A.K., Singh S.P., Rathi A.K., Bhargava R., Abhyankar A., Verma S.K., Rao P.V., and Sekhar K. Japanese encephalitis outbreak, India, 2005. Emerg. Infect. Dis. 12 (2006) 1427-1430
30. Proutski V., Gould E.A., and Holmes E.C. Secondary structure of the 3′ untranslated region of flaviviruses: similarities and differences. Nucleic Acids Res. 25 (1997) 1194-1202
31. Proutski V., Gritsun T.S., Gould E.A., and Holmes E.C. Biological consequences of deletions within the 3′-untranslated region of flaviviruses may be due to rearrangements of RNA secondary structure. Virus Res. 64 (1999) 107-123
32. Rauscher S., Flamm C., Mandl C.W., Heinz F.X., and Stadler P.F. Secondary structure of the 3′-noncoding region of flavivirus genomes: comparative analysis of base pairing probabilities. RNA 3 (1997) 779-791
33. Schwarze S.R., Ho A., Vocero-Akbani A., and Dowdy S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 285 (1999) 1569-1572
34. Shi P.Y. Strategies for the identification of inhibitors of West Nile virus and other flaviviruses. Curr. Opin. Investig. Drugs 3 (2002) 1567-1573
35. Solomon T. Recent advances in Japanese encephalitis. J. Neurovirol. 9 (2003) 274-283
36. Spurgers K.B., Sharkey C.M., Warfield K.L., and Bavari S. Oligonucleotide antiviral therapeutics: antisense and RNA interference for highly pathogenic RNA viruses. Antiviral Res. 78 (2008) 26-36
37. Stein D.A., and Shi P.Y. Nucleic acid-based inhibition of flavivirus infections. Front. Biosci. 13 (2008) 1385-1395
38. Sumiyoshi H., Mori C., Fuke I., Morita K., Kuhara S., Kondou J., Kikuchi Y., Nagamatu H., and Igarashi A. Complete nucleotide sequence of the Japanese encephalitis virus genome RNA. Virology 161 (1987) 497-510
39. Suzuki T., Futaki S., Niwa M., Tanaka S., Ueda K., and Sugiura Y. Possible existence of common internalization mechanisms among arginine-rich peptides. J. Biol. Chem. 277 (2002) 2437-2443
40. Ta M., and Vrati S. Mov34 protein from mouse brain interacts with the 3′ noncoding region of Japanese encephalitis virus. J. Virol. 74 (2000) 5108-5115
41. Thurner C., Witwer C., Hofacker I.L., and Stadler P.F. Conserved RNA secondary structures in Flaviviridae genomes. J. Gen. Virol. 85 (2004) 1113-1124
42. Tsai T.F. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998. Vaccine 18 Suppl. 2 (2000) 1-25
43. Turner J.J., Ivanova G.D., Verbeure B., Williams D., Arzumanov A.A., Abes S., Lebleu B., and Gait M.J. Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells. Nucleic Acids Res. 33 (2005) 6837-6849
44. Tyler B.M., Jansen K., McCormick D.J., Douglas C.L., Boules M., Stewart J.A., Zhao L., Lacy B., Cusack B., Fauq A., and Richelson E. Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 7053-7058
45. Tyler K.N., and Nathanson N. Pathogenesis of viral infections. In: Fields B.N., Knipe D.M., and Howley P.M. (Eds). Fields Virology. 4th ed. (2001), Lippincott/Williams & Wilkins, Philadelphia, PA 199-244
46. Uchil P.D., and Satchidanandam V. Characterization of RNA synthesis, replication mechanism, and in vitro RNA-dependent RNA polymerase activity of Japanese encephalitis virus. Virology 307 (2003) 358-371
47. Vives E., Brodin P., and Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272 (1997) 16010-16017
48. Wender P.A., Mitchell D.J., Pattabiraman K., Pelkey E.T., Steinman L., and Rothbard J.B. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 13003-13008
49. Wittung P., Kajanus J., Edwards K., Haaima G., Nielsen P.E., Nordén B., and Malmström B.G. Phospholipid membrane permeability of peptide nucleic acid. FEBS Lett. 375 (1995) 27-29
50. You S., Falgout B., Markoff L., and Padmanabhan R. In vitro RNA synthesis from exogenous dengue viral RNA templates requires long range interactions between 5′- and 3′-terminal regions that influence RNA structure. J. Biol. Chem. 276 (2001) 15581-15591
51. Yun S.I., Kim S.Y., Rice C.M., and Lee Y.M. Development and application of a reverse genetics system for Japanese encephalitis virus. J. Virol. 77 (2003) 6450-6465
52. Zeng L., Falgout B., and Markoff L. Identification of specific nucleotide sequences within the conserved 3′-SL in the dengue type 2 virus genome required for replication. J. Virol. 72 (1998) 7510-7522
53. Zhao M., and Weissleder R. Intracellular cargo delivery using tat peptide and derivatives. Med. Res. Rev. 24 (2004) 1-12
54. Zuker M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31 (2003) 3406-3415